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Human 92 kDa type IV coIL.. i.tional analysis of fibronectin
and carboxyl-end domains. Two closely related secreted metallopro-
teases 72 and 92 kDa type IV collagenases (72- and 92T4C1) consist of
several structural domains, the functions of which are poorly under-
stood. Both metalloproteases can bind to gelatin as well as form
complexes with specific inhibitors in the proenzyme form. The biologic
role of the proenzyme-inhibitor complex formation remained unclear.
Here we summarize results demonstrating that the fibronectin-like
domain of 92T4C1 mediates gelatin binding of the proenzyme, while the
hemopexin like carboxy-terminal domain is essential for the complex
formation of the proenzyme with TIMP. The formation of a 92T4C1
proenzyme complex with TIMP prevents dimerization, formation of the
novel complex with Cli proenzyme, and activation of the 92T4C1 by
stromelysin. Conversely, formation of the covalent 92T4C1 homodimer
excludes the formation of a proenzyme-TIMP complex, thus allowing
this form of enzyme to enter into the proteolytic cascade of activation.
Both components of the 92T4C1-ClI complex can be activated in a
fashion similar to that of free enzymes, yielding a complex active
against both gelatin and fibrillar collagen.
The extracellular matrix (ECM) metalloproteases secreted by
eucaryotic cells can initiate degradation of ECM macromole-
cules such as collagens and proteoglycans and thus play an
important role in tissue remodeling [reviewed in 1, 2]. A clear
understanding of the structure-function relationship within the
structural domains of these enzymes and their role in mecha-
nisms governing regulation of enzymatic activity in extracellu-
lar space has been a focus of our efforts.
All known ECM metalloproteases contain the amino termi-
nal, zinc binding, and hemopexin-like carboxyl terminal (with
the exception of PUMP-l) domains. Type IV collagenases are
distinguished from the other members of the family by the
presence of three contiguous copies of the fibronectin (FN) type
II homology unit (T2HU). The 92T4C1 protease contains yet an
additional, collagen-like domain [3]. The aminoterminal domain
of these enzymes is responsible for maintenance of the proen-
zyme state [4, 5]. The presence of the fibronectin-like domain in
both 72 and 92 kDa type IV collagenases [3, 6] coincides with
their ability to bind gelatin in a proenzyme form. The zinc
binding domain comprises an active center by analogy with the
similar structure of the well characterized bacterial metalloen-
dopeptidase thermolysin [7, 8]. The functions of the collagen-
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like and carboxyl terminal hemopexin-like domains are poorly
understood.
Methods
The construction of plasmids, carrying portions of 92T4C1
cDNA, was reported in [9, 10]. Site directed mutagenesis was
performed using PCR with synthetic primers [11]. The structure
of each clone generated with PCR was confirmed by sequenc-
ing.
T2HU-f3-galactosidase fusion proteins were isolated using
gelatin affinity chromatography from E. co/i cell extracts, and
3-galactosidase activity was assayed with o-nitrophenol-f3-D-
galactopyranoside (ONPG). The gelatin binding of the purified
fusion proteins was quantified by measuring the amount of
/3-galactosidase activity retained in the gelatin coated 96-well
plates as in [9].
p2AHT2a [12] and U937 cells were cultured in RPMI-1640
medium supplemented with fetal calf serum. U937 were treated
with 12-O-tetradecanoylphorbol acetate (TPA) or with TPA in
combination with lipopolysaccharide (LPS) in RPMI-1640 with
0.1% fetal serum for 48 hours [10].
The 92T4C1 was purified from the conditioned media of
p2AHT2a cells stably transfected with wild type or mutant
cDNAs and from TPA-treated polymorphonuclear leukocytes
(PMN) [3] and U937 cells as described [10].
Gel-filtration chromatography with or without recombinant
TIMP (recTIMP), gel electrophoresis, Western blot and protein
sequence analysis were performed as described [3, 10].
92T4C1 and Cli activity was measured against [14C]-labeled
gelatin and [14C]-labeled fibrillar collagen, respectively [13].
Collagenase proenzymes were activated with either 1 msi
p-aminophenylmercuric acetate (APMA) or plasmin or trypsin-
activated stromelysin [14] for one hour at 37°C [10]. Specific
activity is expressed in U/mg of enzyme where 1 unit = 1 g of
substrate degraded per minute.
Results and discussion
In contrast to other secreted ECM metalloproteases, both 72-
and 92T4C1 proenzymes bind to gelatin and form complexes
with specific inhibitors TIMP-2 and TIMP, respectively. Here
we summarize the experiments elucidating the role of fibronec-
tin and hemopexin like carboxyl terminal domain in these
intermolecular interactions involving 92T4C1 [9, 10].
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Fig. 1. Alignment of T2HU repeats from 92T4C1. Numbers indicate amino acid residues according to the sequence of 92T4C1 [4]. Relatively
hydrophilic regions are overlined. T2HU-2 was subjected to alanine scanning mutagenesis (substituted residues are underlined). T2HU-l was
mutagenized at the positions indicated with asterisks. Residues found to be essential for gelatin binding are shown in bold.
Functional analysis of the fibronectin-like domain of 92 kDa
type IV collagenase by alanine scanning muta genesis
The fibronectin-like domain of both 72 and 92T4Cls [3]
consists of three contiguous copies of fibronectin type II
homology unit: T2HU-l (amino acid positions 216-274),
T2HU-2 (275-332), and T2HU-3 (333-391) which are aligned in
Figure 1. To ascertain whether the presence of this domain can
account for the gelatin binding properties of the proenzyme we
constructed five cDNA clones coding for fusion proteins be-
tween 3-galactosidase and each of the following protein seg-
ments: T2HU-l, T2HU-2, T2HU-3, T2HU1+2 and the entire
FN-like domain (T2HU-1 +2+3). Gelatin binding activity of the
purified fusion proteins was characterized using gelatin coated
microtiter plates. The results demonstrated that the fusion
protein containing T2HU-2 binds at least several-fold more
efficiently than that containing T2HU-3. The T2HU-1 contain-
ing fusion protein has negligible binding activity.
Alanine scanning mutagenesis [15] was used to determine
which amino acid residues within the T2HU-2 are essential for
binding to gelatin. Alanine was substituted for each of the
potentially surface exposed amino acid residues and gelatin
binding of mutant T2HU-2 fusion proteins was measured com-
pare to wild type. Gelatin binding was strongly reduced (>85%)
in seven of the alanine substitutions mutants (Arg307, Asp309,
Trp313, Cys314, Asn319, Tyr320, Asp323), while the remaining 11
substitutions had little or no effect on gelatin binding.
Six out of seven substitutions causing inactivation of gelatin
binding activity affected amino acid residues that are conserved
in all three copies of T2HU in 92T4C1. The remaining residue,
Tyr320, is conserved in all but T2HU-3 where it is replaced with
Phe. This conservation pattern of the essential amino acid
residues does not explain the differences in gelatin binding
activity of the three T2HU repeats present in the enzyme. To
identify the amino acid residues responsible for the low gelatin
binding activity of T2HU-l compared to T2HU-2, we muta-
genized the fusion protein containing T2HU-1 to improve its
gelatin binding activity.
Each of the two non-conserved pairs of A1a228-Ala and
Leu253-Pro in the T2HU- 1 were substituted for the correspond-
ing amino acid residues Lys286-Pro and Tyr311-Arg from
T2HU-2 respectively. Two resulting mutants of the T2HU-1
fusion protein, T2HU-l kp and T2HU yr showed a significant
increase in gelatin binding capacity compared to the parental
T2HU-1 fusion, demonstrating that the difference in binding
capacity between T2HU-l and -2 is traceable to these four
amino acid residues.
The results of alanine scanning mutagenesis of the T2HU-2
permitted identification of amino acid residues defining the
gelatinbinding site and correlate well with the proposed tertiary
structure of the T2HU based on NMR data [16] and crystallo-
graphic analysis of the distantly related prothrombin Krmgle 1
tertiary structure [17]. The main features of this structure
include a homologous hydrophobic core centered around two
perpendicular disulfide bridges, Cys288 with Cys314 and Cys302
with Cys329. The extensive divergence at the exterior of the
structure evolved to provide for different binding specificities.
The NMR analysis of PDC-109 derived T2HU structure [16] is
in general agreement with the arrangement proposed by Hol-
land, Harlos and Blake [17], but predicts a different global
folding of the domain so that the exterior loop 2 (317-324) and
stretch of exposed residues (303-312) are much closer together
according to the NMR data. This loop arrangement allows
formation of a shallow depression with a solvent-exposed
hydrophobic surface that may define a binding site [16].
Our results demonstrating the inactivation of binding activity
by substitution of Ala for Arg307, Asp309, Asn3i9 Tyr320, and
Asp323 residues, which both tertiary structure models place
within the solvent exposed stretch, suggest that these residues
are critical in defining the binding site. The inactivation by
substitution of Ala for Trp3i3 is more difficult to interpret, since
its proximity to the surface is a matter of discrepancy between
two proposed structures. The Trp313 side chains are apparently
positioned in a hydrophobic cavity [17] next to Cys3i4 and may
be essential for the proper folding of FN-like domain leading,
therefore, to a similar phenotype as the substitution of Cys314.
However, according to the NMR data this side chain is more
exposed [161 and may participate in contact with a substrate. It
should be noted that these amino acid residues are also highly
conserved in all three copies of T2HU in the 72 kDa enzyme as
well as FN. The exceptions are Asn319 and Tyr320, which are
substituted with, respectively, Asp in T2HU-2 [3] and Phe in
T2HU-l of 72T4C1 [6] as well as T2HU-3 of 92T4C1. The four
conserved cysteine residues of the T2HU are essential [18] for
gelatin binding by FN, and this is confirmed by the alanine
substitution of Cys3i4 which leads to complete loss of gelatin
binding.
It is important to notice that the sequence within the solvent-
exposed stretch of residues (303-312) is not conserved in
PDC-109derived T2HU, which binds gelatin effectively [191. At
the same time, despite strong sequence conservation in the
same region among the three CLG4B derived T2HU their
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Table 1. Properties of the 92T4C1 mutants
Enzyme
Formation of
Homodimer
ProenzymelTlMP
complex
p2A92c8 wild type
p2A92s1 1 70 1-707 deletion
p2A92sl2 Gly for Cys674
p2A92s15 Ala for Cys704
p2A92s12l5 double mutant
+
+
+
+
+
+
—
—
—
—
gelatin binding capacity differs significantly. T2HU-2 possesses
most of the activity.
Why then does the FN-like domain contain three copies of
the T2HU if one copy is sufficient to specify binding? One
possible explanation is that each repeat of T2HU in the domain
may have evolved to optimize the interaction with different
sites or components of the extracellular matrix, and in doing so
sustained a loss in gelatin binding capacity. If this hypothesis is
correct, one should be able to discriminate among such different
binding sites by using the individual T2HU as probes.
Our data support the hypothesis that the gelatin binding of the
92T4C1 proenzyme is mediated through fibronectin-like domain.
Surprisingly, the results demonstrate that this binding is not a
rate limiting step in gelatin hydrolysis by 92T4C1. Gelatin
binding of the proenzyme as well as T2HU-2 fusion is inhibited
(>90%) in the presence of the non-polar solvent DMSO (10%
vollvol). This concentration of DMSO, however, has no effect
on proteolytic activity of the 92T4C1 against either gelatin or
synthetic hexapeptide acetyl-Pro-Leu-Gly-Val-Leu-Gly-O-
C2H5 substrates. This observation suggests a possibility that
presence of other substrate binding site(s) cannot be excluded.
Functional analysis of C-terminal hemopexin-like domain of
92T4C1 and the role of proenzyme complex with inhibitor
TIMP
Mutants of the 92T4C1 proenzyme unable to bind TIMP.
Earlier we demonstrated that 72- and 92T4C1 proenzymes, in
contrast to interstitial procollagenase, form a stable stoichio-
metric complex with the specific inhibitors, TIMP-2 and TIMP
respectively [3, 201. To investigate the physiologic role of
complex formation between the 92T4C1 proenzyme and TIMP,
we obtained enzyme mutants unable to form such a complex.
Deletion mapping of the carboxyl terminal domain of the
enzyme was accomplished using site directed mutagenesis to
introduce premature termination codons within the 92T4C1
cDNA coding for 707 amino acid residues. The wild type and
mutant cDNAs were cloned into a p6RHyg expression vector
[101 and transfected into p2AHT2a host cells [12]. Secreted
92T4C1 was purified and the resulting protein was analyzed for
the presence of TIMP. The wild type 92T4C1 proenzyme
(p2A92c8) was found in a complex with TIMP similar to that
obtained from the HT1O8O and U937 cells [161. Deletion of eight
amino acid residues from the carboxyl end of the enzyme
(mutant p2A92s14) was sufficient to abolish proenzyme-inhibi-
tor complex formation (Table 1). This deletion of eight amino
acids includes a Cys704 residue, which subsequent mutagenesis
showed is essential for proenzyme-TIMP interaction. The ho-
mology alignment of secreted metalloproteases [3] shows that
the hemopexin-like C-end domain of each protease contains
two conserved cysteine residues (Cys516 and Cys704 in the
92T4C1). The 92T4C1 contains an additional pair of cysteine
residues, Cys468 and Cys674, positioned in the center of the
collagen-like domain and in the carboxyl end domain of the
enzyme, respectively. The conservation of the disulfide bridges
within the carboxyl end domains of metalloproteases implies
that the conserved Cys516-Cys704 pair and the additional pair of
Cys468-Cys674 residues form disulfide bridges.
Three additional 92T4C1 mutants, p2A92s12, in which Gly
was substituted for the Cys674 residue, p2A92sl5 containing an
Ala substitution for Cys704 and the p92s1215 mutant containing
both substitutions, were isolated. TIMP was completely absent
in purified preparations of p2A92s 15 and the double mutant
p2A92s1215, suggesting that the formation of the proenzyme-
inhibitor complex is abolished in the absence of the disulfide
bridge involving the conserved Cys704 residue. Substitution of
Cys674 did not affect this interaction since the purified enzyme
p2A92s12 was in complex with TIMP.
The ability of the mutants to form the proenzyme-inhibitor
complex in vitro was analyzed by gel filtration chromatography.
Purified wild type and mutant 92T4C1 were preincubated with a
threefold molar excess of recTIMP prior to chromatography.
The mixture was subjected to gel filtration on an AcA-44
column, and protein peaks were analyzed on PAGE for pres-
ence of the unglycosylated recTIMP which was readily distin-
guishable from the native glycosylated inhibitor. The Cys704
substitution mutant p2A92s15 was unable to form a complex
with recTIMP in vitro (Table 1), in contrast to wild type and the
p2A92sl2 enzymes.
Dimerization of the 92T4C1 prevents proenzyme-inhibitor
complex formation. Both wild type and mutant enzymes se-
creted by transfected cells exhibit an enhanced ability to form
dimers compared to the enzyme secreted by HT1O8O or phorbol
ester-induced U937 cells. We purified the wild-type p2A92c8
and p2A92s12 mutant enzymes and separated their homodimers
from monomeric forms on a gelatin affinity column developed
with 0 to 10% DMSO gradient. In contrast to enzyme mono-
mers, covalent homodimers of p2A92c8 and p2A92s12 enzymes
lacked any detectable amount of TIMP and were unable to form
a complex with TIMP in vitro as was demonstrated using gel
filtration chromatography. These results demonstrate that (i.)
the formation of the covalent 92T4C1 homodimer precludes
formation of the proenzyme-inhibitor complex; and (ii.) the
protein moieties responsible for dimerization of the 92T4C1 and
complex formation with TIMP are structurally distinct.
Interstitial procollagenase forms a stable non-covalent com-
plex with 92T4C1, which can be displaced by TIMP. Most of the
cells secreting 92T4C1 we previously investigated [31 did not
secrete large amount of interstitial collagenase (Cli). The U937
cells undergo TPA induced differentiation towards macrophage
and secrete metalloproteases [3, 21], including 92T4C1 in com-
plex with TIMP and moderate amounts of Cli. Simultaneous
treatment of these cells with TPA and lipopolysaccharide (LPS)
causes a dramatic, up to 80-fold, increase in synthesis of Cli
compared to cells treated with TPA alone. The 92T4C1 purified
from the conditioned media of the TPAILPS treated cells was
found in a stoichiometric non-covalent complex with CII proen-
zyme.
The existence of a TIMP free 92T4C1-ClI complex raises the
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question as to how this complex relates to the 92T4C1 proen-
zyme-TIMP complex. To address this question we subjected
the 92T4C1-ClI complex to gel filtration chromatography with or
without the addition of exogenous recTIMP. The 92T4C1-ClI
complex remained intact after gel filtration chromatography.
However, the addition of recTIMP to this complex prior to
chromatography caused the mixture to separate into three
peaks. The first peak contained 92T4C1 and recTIMP but no
longer contained Cli. Cli was displaced from the complex and
migrated as a second peak corresponding to the position of the
free enzyme on this column. The third peak consisted of free
recTIMP. This experiment demonstrates that: (i.) 92T4C1 can
form a novel stable complex with Cli; and (ii.) Cl! can be
displaced from this complex by TIMP with simultaneous re-
lease of the 92T4C1-TIMP complex and free Cl! proenzyme,
suggesting that the sites of Cli and TIMP interaction with
92T4C1 overlap.
Taken together these data indicate that in the presence of a
sufficient amount of TIMP, relative to the enzyme, 92T4C1
forms a proenzyme-inhibitor complex. Alternatively, under the
conditions of enzyme excess relative to inhibitor, the 92T4C1
monomer forms either a TIMP-free homodimer or a novel
complex with interstitial collagenase. The proenzyme ho-
modimer is unable to form a complex with TIMP. Interaction of
the 92T4C1-ClI complex with TIMP causes release of free Cli
with formation of the 92T4C1-TIMP complex.
All TIMP-free forms of 92T4C1 can be activated by strome-
lysin. Having isolated several of the 92T4C1 forms free of TIMP
including the complex of 92T4C1 with CII, the 92T4C1 ho-
modimer, and mutant enzymes unable to form a proenzyme-
inhibitor complex, we investigated whether the association of
native proenzyme with TIMP prevents activation of the enzyme
under physiologic conditions. Treatment of the 92T4C1 with
plasmin activated stromelysin at a molar ratio 1:20 to 1:160 (1
hr, 37°C) resulted in activation of all TIMP free forms of the
92T4C1. The TIMP free wild-type 92T4C1 homodimer and the
92T4C1 in complex with the C1I were fully activated, whereas
no significant activation of Cl! itself was observed. Activation
of the wild type enzyme with the low amount of stromelysin
resulted in accumulation of an 88 kDa intermediate, while the
increased amount of stromelysin led to accumulation of the final
activation product with the molecular mass of 84 kDa. The
proteolytic processing occurred within the aminoterminal do-
main of the 92T4C1 proenzyme, as was demonstrated by amino
acid sequencing of the activated enzyme species. The amino
terminal sequence of 88 and 84 kDa activation products of
92T4C1 proenzyme start from Met6° and Phe'°7 residues, re-
spectively. The stoichiometric 92T4C1-TIMP complex was re-
sistant to activation with stromelysin.
These results demonstrate that stromelysin is an activator of
the 92T4C1 proenzyme and the formation of the proenzyme-
inhibitor complex prevents this activation. In contrast to
stromelysin, plasmin activation of 92T4C1 required a much
higher ratio of plasmin!proenzyme than was required for acti-
vation with stromelysin. The specific activity of plasmin acti-
vated enzymes was about 50 times lower compared to strome-
lysin activated enzyme. Our experiments demonstrate that
plasmin, although inefficiently, can activate only TIMP free
forms of 92T4C1 but not 92T4C1 in complex with TIMP. All
TIMP-free forms of pro-92T4C1 can be activated by strome-
Activation with
Enzyme Stromelysin APMA Plasmin
Plasminl
stromelysin
92T4C1-TIMP 5500
92T4C1 dimer 20000 13100 105
92T4C1-C1I 15700 19700 240
p2A92s12 monomer 11500
p2A92s12 dimer 14700 17000 100
pA292s15 22370 12500 250
92T4ClproCIIa 460° NA 160°
NA
NA
NA
NA
NA
NA
2750°
Enzymes were activated with either 1 msi APMA, stromelysin at a
1:20 stromelysin/enzyme ratio or plasmin at a 1:1 ratio of plasminl
enzyme for 1 hour at 37°C. Gelatinolytic activity was measured against
[14C]gelatin as described [20]. Activity is expressed in units/mg of
protein where I unit = 1 g of substrate digested in I mm.
a Activation of interstitial collagenase in 92T4C1-ClI complex; I igof
92T4C1-ClI complex was activated with 0.2 jg of plasmin and/or 0.02 g
of trypsin-activated stromelysin. The activity was measured against
fibrillar ['4C] guinea pig skin collagen as described [4]. The 92T4C1 was
completely inactive against this substrate [3].
lysin. Formation of a 92T4C1-TIMP complex prevents activa-
tion of 92T4C1, demonstrating a new role for TIMP in the
metabolism of 92T4C1 and a physiologic role for proenzyme-
inhibitor complex formation. A similar complex between
72T4C1 and TIMP-2 is likely to serve the same function in the
metabolism of this enzyme.
How does the formation of the complex with 92T4C1 affect
the activation of the interstitial collagenase? Collagenase I,
present in a TIMP-free complex with 92T4C1, was largely
resistant to activation by stromelysin alone, similar to the free
enzyme [5]. The 92T4C1 component of this complex was readily
activated under these conditions. Accordingly, the stromelysin
activated complex acquired gelatinolytic activity, while remain-
ing relatively inactive against fibrillar collagen (Table 2). In
contrast, plasmin was able to efficiently convert CII into the 42
kDa form susceptible to further rapid activation by stromelysin
[5, 22, 231. After plasmin activation the 92T4C1-ClI complex had
low specific activity against gelatin and collagen substrates. The
addition of stromelysin to this plasmin pre-activated complex
caused a rapid activation of both components generating a
complex with high specific activity against both soluble gelatin
and fibrillar collagen substrates. These results demonstrate that
interstitial collagenase in complex with 92T4C1 is activated by
the mechanism characteristic of free enzyme [5]. The existence
of the 92T4C1-ClI complex suggests the possibility of a cooper-
ative action between the two enzymes in the degradation of
fibrillar collagen to small peptides under physiologic condi-
tions—a task which cannot be accomplished efficiently by
either enzyme alone.
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Appendix. Abbreviations
Abbreviations are: ECM, extracellular matrix; PMN, polymorpho-
nuclear leukocytes; FN, fibronectin; T2HU, type II homology unit;
92T4C1 and 72T4Cl, 92 kDa and 72 kDa Type IV collagenases respec-
tively; CII, type I interstitial collagenase; TIMP, tissue inhibitor of
metalloproteases; recTIMP, recombinant TIMP; PCR, polymerase
chain reaction; ONPG, o-nitrophenol-/3-D-galactopyranoside; TPA, 12-
O-tetradecanoylphorbol acetate; LPS, lipopolysaccharide; APMA,
p-aminophenylmercuric acetate; DMSO, dimethyl sulfoxide.
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